Disease-related research focuses primarily on melanoma, drug-related research on anti-CTLA-4 monoclonal antibodies and anti-PD-1 monoclonal antibodies, and adverse events research on autoimmune hypophysitis and diabetes. This evidence concerns the gene CTLA4 and melanoma.